Senti Biosciences Inc Cash Flow-to-Debt Ratio
Senti Biosciences Inc cash flow-to-debt ratio. Senti Biosciences Inc (SNTI) has a Cash Flow-to-Debt Ratio of -0.21x as of September 2025, meaning its operating cash flow of $-9.45 Million could theoretically repay 0% of its total liabilities ($44.56 Million) in one year. See Senti Biosciences Inc free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Senti Biosciences Inc (2019–2024)
Cash flow-to-debt ratio of Senti Biosciences Inc from 2019 to 2024. Historical debt coverage capacity for Senti Biosciences Inc across 6 annual periods. Also explore SNTI year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Senti Biosciences Inc Cash Flow-to-Debt Ratio by Year (2019–2024)
Senti Biosciences Inc cash flow-to-debt ratio by year from 2019 to 2024. Year-by-year debt coverage analysis for Senti Biosciences Inc. For the full cash flow conversion analysis, see SNTI cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.57x | $-41.40 Million | $72.19 Million | ▲ +42.5% |
| 2023 | -1.00x | $-52.40 Million | $52.57 Million | ▼ -52.9% |
| 2022 | -0.65x | $-34.90 Million | $53.53 Million | ▲ +31.6% |
| 2021 | -0.95x | $-34.63 Million | $36.33 Million | ▼ -322.3% |
| 2020 | -0.23x | $-24.17 Million | $107.06 Million | ▲ +78.0% |
| 2019 | -1.03x | $-18.38 Million | $17.88 Million | — |